Calendar

Week of Sep 22, 2025

Sep 24, 2025grant330d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — TMS Neuromodulation of Brain-to-Stomach Circuits in Chronic Nausea

DK grant. $656,104. PI: DAVID J LEVINTHAL

full page →nih reporter ↗

Sep 24, 2025grant330d agoUNIVERSITY OF LOUISVILLE — Development of novel antivirals for arthritogenic alphaviruses

AI grant. $544,521. PI: Thomas D Bannister

full page →nih reporter ↗

Sep 24, 2025grant330d agoRHODE ISLAND HOSPITAL — An RCT to Evaluate Treatment Modalities to Halt the Progression of Schistosom...

AI grant. $328,265. PI: JENNIFER F FRIEDMAN

full page →nih reporter ↗

Sep 24, 2025grant330d agoUNIVERSITY OF ROCHESTER — Ribosomal Frameshifting in HIV-1 Infection, Inflammation and NeurotoxicityUniversity of Rochester

NS grant. $601,307. PI: Yiping Zhu

full page →nih reporter ↗

Sep 24, 2025grant330d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Contributions of Volume Overload Level and Ultrafiltration to Morbidity in ESKDUniversity of California San Francisco

DK grant. $737,949. PI: Cynthia Delgado

full page →nih reporter ↗

Sep 24, 2025grant330d agoNATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY — Elucidation of the role of Plasmodium falciparum folate transporters in antif...

AI grant. $60,588. PI: Marie Hoarau

full page →nih reporter ↗

Sep 24, 2025grant330d agoUNIVERSITY OF GHANA — Assessing mechanisms for the persistence of RNA viruses in bats using a capti...

AI grant. $146,125. PI: Osbourne Quaye

full page →nih reporter ↗

Sep 24, 2025grant330d agoWASHINGTON UNIVERSITY — Natural killer cells subvert immune checkpoint therapy of tumors

CA grant. $3,182,665. PI: Wayne M. Yokoyama

full page →nih reporter ↗

Sep 24, 2025grant330d agoNEW YORK UNIVERSITY D/B/A NYU LONG ISLAND SCHOOL OF MEDICINE — Reducing Plasma Cholesterol and Atherosclerosis Using miR-30c Analog C2New York University

HL grant. $1,364,153. PI: M Mahmood Hussain

full page →nih reporter ↗

Sep 24, 2025grant330d agoUNIVERSITY OF WASHINGTON — Proteomic and Genomic Discovery of Targets for Atrial Cardiopathy-Related Car...University of Washington

HL grant. $1,657,473. PI: Lin Yee Chen

full page →nih reporter ↗

Sep 24, 2025grant330d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Life-course stressors, Mitochondrial Dysfunction, and the Risk of Preterm Bir...

MD grant. $129,748. PI: Tingting Zhao

full page →nih reporter ↗

Sep 24, 2025grant330d agoYALE UNIVERSITY — Building effective EB services at New Haven Adult Education

MH grant. $754,123. PI: Derrick M Gordon

full page →nih reporter ↗

Sep 24, 2025grant330d agoGEORGE MASON UNIVERSITY — Adaptation and pilot trial of an intervention to reduce intimate partner viol...

MH grant. $674,483. PI: Jhumka Gupta

full page →nih reporter ↗

Sep 24, 2025grant330d agoWRIGHT STATE UNIVERSITY — Installation of a reverse osmosis water treatment system in LAR

OD grant. $174,350. PI: Emily Dudley

full page →nih reporter ↗

Sep 24, 2025grant330d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Developing the Optimal Prehabilitation Program for Kidney Transplant Candidat...New York University

DK grant. $842,633. PI: Babak John Orandi

full page →nih reporter ↗

Sep 24, 2025grant330d agoTULANE UNIVERSITY OF LOUISIANA — Epigenetic Control of Nephron Progenitor Cell Lifespan

DK grant. $633,272. PI: Samir S El-Dahr

full page →nih reporter ↗

Sep 24, 2025grant330d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Investigating Rab8 Phosphorylation and AMPA Receptor Trafficking in the LRRK2...

NS grant. $49,538. PI: Alexander Tielemans

full page →nih reporter ↗

Sep 24, 2025grant330d agoUNIV OF MARYLAND, COLLEGE PARK — Role of tryptophan catabolism and AHR pathways in natural resistance of Leish...

AI grant. $71,630. PI: Najib M El-Sayed

full page →nih reporter ↗

Sep 24, 2025grant330d agoGEORGIA STATE UNIVERSITY — Transgenic mouse models of disease to test an innovative OMV-based vaccine fo...

AI grant. $300,744. PI: CYNTHIA N CORNELISSEN

full page →nih reporter ↗

Sep 24, 2025grant330d agoPARAMITA THERAPEUTICS, INC. — Novel multivalent PSMA-targeted taxane-conjugates for bone metastases in pros...

CA grant. $353,009. PI: Sang Van

full page →nih reporter ↗

Sep 24, 2025grant330d agoORPRO THERAPEUTICS, INC. — Engineered Monothiol Thioredoxin for Treatment of Radiation Induced Lung Injury

HL grant. $508,988. PI: Peter B Heifetz

full page →nih reporter ↗

Sep 24, 2025grant330d agoOREGON HEALTH & SCIENCE UNIVERSITY — In vivo investigations of astrocyte-oligodendrocyte interactions

NS grant. $429,000. PI: Kelly R Monk

full page →nih reporter ↗

Sep 24, 2025grant330d agoSIBEL INC. — Novel AI-Enabled Wearable Sensor for Scratch Monitoring

FD grant. $249,999. PI: Shuai Xu

full page →nih reporter ↗

Sep 24, 2025grant330d agoLOCUS BIOSCIENCES, INC. — Development of Therapeutic Candidates for Antibiotic Resistant BacteriaLocus Biosciences Inc

AI grant. $3,318,955. PI: Paul Joon Kim

full page →nih reporter ↗

Sep 24, 2025grant330d agoZENVAX, LLC — Use a humanized monoclonal antibody as an emergency prophylactic and therapeu...

AI grant. $301,674. PI: Guoquan Zhang

full page →nih reporter ↗

Sep 24, 2025grant330d agoVENA VITALS, INC. — Continuous Non-Invasive Blood Pressure during Sleep as a Cardiovascular Bioma...

HL grant. $306,872. PI: Joshua Kim

full page →nih reporter ↗

Sep 24, 2025grant330d agoLEIDOS BIOMEDICAL RESEARCH, INC. — FY25 TO-H W3F1 RENOVATIONS

CA grant. $1,856,809. PI: lynn briscoe

full page →nih reporter ↗

Sep 25, 2025approval329d agoITOVEBI (INAVOLISIB) — FDA approvalinavolisib

Sponsor: GENENTECH INC. Form: TABLET. Route: ORAL

full page →inavolisib →fda approvals ↗

Sep 25, 2025approval329d agoALYFTREK (DEUTIVACAFTOR) — FDA approval(deutivacaftor + tezacaftor + vanzacaftor calcium)

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →(deutivacaftor + tezacaftor + vanzacaftor calcium) →fda approvals ↗

Sep 25, 2025approval329d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →TRIKAFTA (COPACKAGED) →fda approvals ↗

Sep 25, 2025approval329d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

Sponsor: VERTEX PHARMS INC. Form: GRANULES. Route: ORAL

full page →TRIKAFTA (COPACKAGED) →fda approvals ↗

Sep 25, 2025approval329d agoORKAMBI (IVACAFTOR) — FDA approval(ivacaftor + lumacaftor)

Sponsor: VERTEX PHARMS INC. Form: GRANULE. Route: ORAL

full page →(ivacaftor + lumacaftor) →fda approvals ↗

Sep 25, 2025approval329d agoKALYDECO (IVACAFTOR) — FDA approvalVertex, Inc.

Sponsor: VERTEX PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 25, 2025approval329d agoKALYDECO (IVACAFTOR) — FDA approvalivacaftor

Sponsor: VERTEX PHARMS INC. Form: GRANULE. Route: ORAL

full page →ivacaftor →fda approvals ↗

Sep 25, 2025approval329d agoORKAMBI (IVACAFTOR) — FDA approval(ivacaftor + lumacaftor)

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →(ivacaftor + lumacaftor) →fda approvals ↗

Sep 25, 2025approval329d agoSYMDEKO (COPACKAGED) (IVACAFTOR) — FDA approvalivacaftor

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →ivacaftor →fda approvals ↗

Sep 25, 2025approval329d agoZEPBOUND (TIRZEPATIDE) — FDA approvalZEPBOUND

Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →ZEPBOUND →fda approvals ↗

Sep 25, 2025approval329d agoROBINUL (GLYCOPYRROLATE) — FDA approvalGLYCOPYRROLATE

Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

full page →GLYCOPYRROLATE →fda approvals ↗

Sep 25, 2025approval329d agoMOUNJARO (TIRZEPATIDE) — FDA approvalZEPBOUND

Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →ZEPBOUND →fda approvals ↗

Sep 25, 2025approval329d agoFENTANYL CITRATE — FDA approvalEffentora

Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

full page →Effentora →fda approvals ↗

Sep 25, 2025approval329d agoWEZLANA (USTEKINUMAB-AUUB) — FDA approvalWEZLANA

Sponsor: AMGEN INC. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS

full page →WEZLANA →fda approvals ↗

Sep 25, 2025approval329d agoWEZLANA (USTEKINUMAB-AUUB) — FDA approvalWEZLANA

Sponsor: AMGEN INC. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS

full page →WEZLANA →fda approvals ↗

Sep 25, 2025approval329d agoINLURIYO (IMLUNESTRANT TOSYLATE) — FDA approvalimlunestrant tosylate

Sponsor: ELI LILLY AND CO. Form: TABLET. Route: ORAL

full page →imlunestrant tosylate →fda approvals ↗

Sep 25, 2025approval329d agoCEFUROXIME AXETIL — FDA approvalOrchid Pharma Inc

Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 25, 2025approval329d agoCEFUROXIME AXETIL — FDA approvalOrchid Pharma Inc

Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 25, 2025approval329d agoCEFUROXIME AXETIL — FDA approvalOrchid Pharma Inc

Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Sep 25, 2025approval329d agoPALSONIFY (PALTUSOTINE HYDROCHLORIDE) — FDA approvalpaltusotine hydrochloride

Sponsor: CRINETICS. Form: TABLET. Route: ORAL

full page →paltusotine hydrochloride →fda approvals ↗

Sep 25, 2025approval329d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: AVANTHI INC. Form: CAPSULE. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗

Sep 25, 2025approval329d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: AVANTHI INC. Form: CAPSULE. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗

Sep 25, 2025approval329d agoEVKEEZA (EVINACUMAB-DGNB) — FDA approvalevinacumab

Sponsor: REGENERON PHARMACEUTICALS. Form: SOLUTION. Route: INJECTION

full page →evinacumab →fda approvals ↗

← prev

page 68 of 372

Week of Sep 22, 2025